BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerating Global Expansion
- Written by PR Newswire
 |
- BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC), following GMP certifications in Brazil(a PIC/S member), Colombia, Egypt, Indonesia, and Argentina—further strengthening its global presence by opening access to the African market.
- Backed...
